![Scott D. Wilkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott D. Wilkin
Analyst-Equity at
UBS Asset Management (UK) Ltd.
Profile
Scott D.
Wilkin is currently Head of Global Equity at UBS Asset Management (UK) Ltd. since 2016.
Formerly, Mr. Wilkin was Director of Research & Portfolio Manager at UBS Asset Management (Americas) LLC from 2012 to 2016.
Other former roles include Managing Director at Cowen & Co. LLC and SG Cowen Securities Corp., Manager of Business Development at Dura Pharmaceuticals, Inc. from 1995 to 1997, Analyst at Warburg Dillon Read LLC from 1997 to 1999, and Market Research Consultant at Boston Biomedical Consultants, Inc. Education includes an undergraduate degree from Bowdoin College in 1990 and an MBA from Harvard Business School.
Scott D. Wilkin active positions
| Companies | Position | Start |
|---|---|---|
UBS Asset Management (UK) Ltd.
 UBS Asset Management (UK) Ltd. Investment ManagersFinance UBS-UK is an active, long-term manager which utilizes integrated investment platforms and a range of investment strategies. The firm employs global tactical asset allocation to take advantage of valuation anomalies through derivatives, both in markets and in currencies. Their investment approach is team-oriented and based on fundamental and proprietary quantitative research generated in-house on a global basis. They aim for a local sector-neutral portfolio selection, which is then used to create global portfolios. UBS-UK invests in equity, fixed-income, hedge funds, liquidity and cash, multi-asset, real assets/PE, and passive/ETFs. | Analyst-Equity | 2016-07-31 |
Former positions of Scott D. Wilkin
| Companies | Position | End |
|---|---|---|
Warburg Dillon Read LLC
 Warburg Dillon Read LLC Investment Banks/BrokersFinance Provides securities brokerage services | Analyst-Equity | - |
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Corporate Officer/Principal | - |
Boston Biomedical Consultants, Inc.
 Boston Biomedical Consultants, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services to health industry | Corporate Officer/Principal | - |
SG Cowen Securities Corp.
 SG Cowen Securities Corp. Investment Banks/BrokersFinance Provides securities brokerage services | Corporate Officer/Principal | - |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Training of Scott D. Wilkin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
UBS Asset Management (Americas) LLC
 UBS Asset Management (Americas) LLC Investment ManagersFinance UBS AM offers Equities, Fixed Income, Indexing, and Investment Solutions businesses. The firm provides active investment strategies to their clients and principally employs fundamental analysis in managing client accounts by attempting to identify discrepancies between current market prices and their estimate of fundamental value. | Finance |
Dura Pharmaceuticals, Inc.
Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
UBS Asset Management (UK) Ltd.
UBS Asset Management (UK) Ltd. Investment ManagersFinance UBS-UK is an active, long-term manager which utilizes integrated investment platforms and a range of investment strategies. The firm employs global tactical asset allocation to take advantage of valuation anomalies through derivatives, both in markets and in currencies. Their investment approach is team-oriented and based on fundamental and proprietary quantitative research generated in-house on a global basis. They aim for a local sector-neutral portfolio selection, which is then used to create global portfolios. UBS-UK invests in equity, fixed-income, hedge funds, liquidity and cash, multi-asset, real assets/PE, and passive/ETFs. | Finance |
Warburg Dillon Read LLC
Warburg Dillon Read LLC Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SG Cowen Securities Corp.
SG Cowen Securities Corp. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Boston Biomedical Consultants, Inc.
Boston Biomedical Consultants, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services to health industry | Commercial Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Scott D. Wilkin
